Immunome Inc (IMNM)
12.82
+1.23
(+10.61%)
USD |
NASDAQ |
Nov 04, 16:00
12.84
+0.02
(+0.12%)
Pre-Market: 20:00
Immunome Market Cap: 769.90M for Nov. 4, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 04, 2024 | 769.90M |
| November 01, 2024 | 696.03M |
| October 31, 2024 | 688.82M |
| October 30, 2024 | 732.66M |
| October 29, 2024 | 732.66M |
| October 28, 2024 | 746.48M |
| October 25, 2024 | 727.26M |
| October 24, 2024 | 721.25M |
| October 23, 2024 | 696.63M |
| October 22, 2024 | 703.24M |
| October 21, 2024 | 715.25M |
| October 18, 2024 | 737.47M |
| October 17, 2024 | 726.06M |
| October 16, 2024 | 741.07M |
| October 15, 2024 | 731.46M |
| October 14, 2024 | 729.66M |
| October 11, 2024 | 734.47M |
| October 10, 2024 | 712.85M |
| October 09, 2024 | 738.67M |
| October 08, 2024 | 774.70M |
| October 07, 2024 | 747.68M |
| October 04, 2024 | 790.92M |
| October 03, 2024 | 806.53M |
| October 02, 2024 | 810.73M |
| October 01, 2024 | 811.94M |
| Date | Value |
|---|---|
| September 30, 2024 | 878.00M |
| September 27, 2024 | 863.58M |
| September 26, 2024 | 861.18M |
| September 25, 2024 | 856.38M |
| September 24, 2024 | 877.39M |
| September 23, 2024 | 840.76M |
| September 20, 2024 | 900.22M |
| September 19, 2024 | 918.23M |
| September 18, 2024 | 930.84M |
| September 17, 2024 | 924.84M |
| September 16, 2024 | 948.26M |
| September 13, 2024 | 959.07M |
| September 12, 2024 | 883.40M |
| September 11, 2024 | 868.39M |
| September 10, 2024 | 878.60M |
| September 09, 2024 | 878.00M |
| September 06, 2024 | 813.14M |
| September 05, 2024 | 853.97M |
| September 04, 2024 | 883.40M |
| September 03, 2024 | 843.16M |
| August 30, 2024 | 911.63M |
| August 29, 2024 | 915.23M |
| August 28, 2024 | 932.64M |
| August 27, 2024 | 899.01M |
| August 26, 2024 | 943.45M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
26.80M
Minimum
Dec 30 2022
1.563B
Maximum
Mar 07 2024
305.50M
Average
155.59M
Median
Aug 19 2021
Market Cap Benchmarks
| CEL-SCI Corp | 50.89M |
| AIM ImmunoTech Inc | 16.27M |
| IGC Pharma Inc | 28.50M |
| NovaBay Pharmaceuticals Inc | 3.694M |
| Protalix BioTherapeutics Inc | 94.13M |
Market Cap Related Metrics
| PS Ratio | 37.36 |
| Price to Book Value | 3.033 |
| Price | 12.82 |
| Earnings Yield | -122.1% |